ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹124 Cr | ₹165 Cr | ₹222 Cr | ₹442 Cr | ₹519 Cr |
What is the latest Total Non-Current Liabilities ratio of ORCHID PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹124 Cr |
Mar2023 | ₹165 Cr |
Mar2022 | ₹222 Cr |
Mar2021 | ₹442 Cr |
Mar2020 | ₹519 Cr |
How is Total Non-Current Liabilities of ORCHID PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹124 Cr | -24.43 | |
Mar2023 | ₹165 Cr | -25.96 | |
Mar2022 | ₹222 Cr | -49.71 | |
Mar2021 | ₹442 Cr | -14.78 | |
Mar2020 | ₹519 Cr | - |
Compare Total Non-Current Liabilities of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹7,177.9 Cr | -7.7% | -21.7% | 87.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | -7.7% |
-21.7% |
87.1% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses